Intervention for incipient patients at low risk of disease progression ( DrugBank: - )
1 disease
| 告示番号 | 疾患名（ページ内リンク） | 臨床試験数 |
|---|---|---|
| 66 | IgA腎症 | 1 |
66. IgA腎症
臨床試験数 : 255 / 薬物数 : 255 - (DrugBank : 79) / 標的遺伝子数 : 35 - 標的パスウェイ数 : 137
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT04438603 (ClinicalTrials.gov) | October 1, 2020 | 17/6/2020 | The Applicaiton of Immune Repertoire in the Diagnosis and Disease Monitoring of IgA Nephropathy | The Applicaiton of Immune Repertoire in the Diagnosis and Disease Monitoring of IgA Nephropathy | IgA Nephropathy | Drug: Intervention for incipient patients at low risk of disease progression;Drug: Intervention for patients at high risk of disease progression | Xinhua Hospital, Shanghai Jiao Tong University School of Medicine | RenJi Hospital;Shanghai Zhongshan Hospital;Longhua Hospital Shanghai University of Traditional Chinese Medicine | Recruiting | 18 Years | 80 Years | All | 180 | China |